{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T03:08:01Z","timestamp":1775876881215,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1038\/s41416-021-01429-3","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:20:32Z","timestamp":1621495232000},"page":"445-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Persistent neuropathy among early-stage breast cancer survivors in a population-based cohort"],"prefix":"10.1038","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7291-7227","authenticated-orcid":false,"given":"Kristina","family":"Engvall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Gr\u00e9en","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Fredriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"\u00c5vall-Lundqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"1429_CR1","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","volume":"379","author":"R Peto","year":"2012","unstructured":"Peto, R., Davies, C., Godwin, J., Gray, R., Pan, H. C., Clarke, M. et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379, 432\u2013444 (2012).","journal-title":"Lancet"},{"key":"1429_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrclinonc.2009.186","volume":"7","author":"PL Bedard","year":"2010","unstructured":"Bedard, P. L., Di Leo, A. & Piccart-Gebhart, M. J. Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer. Nat. Rev. Clin. Oncol. 7, 22\u201336 (2010).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1429_CR3","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00520-014-2255-7","volume":"22","author":"F Mols","year":"2014","unstructured":"Mols, F., Beijers, T., Vreugdenhil, G. & van de Poll-Franse, L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support. Care Cancer 22, 2261\u20132269 (2014).","journal-title":"Support. Care Cancer"},{"key":"1429_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejca.2014.11.024","volume":"51","author":"L Eckhoff","year":"2015","unstructured":"Eckhoff, L., Knoop, A., Jensen, M. B. & Ewertz, M. Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors. Eur. J. Cancer 51, 292\u2013300 (2015).","journal-title":"Eur. J. Cancer"},{"key":"1429_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s10147-011-0352-x","volume":"18","author":"Y Tanabe","year":"2013","unstructured":"Tanabe, Y., Hashimoto, K., Shimizu, C., Hirakawa, A., Harano, K., Yunokawa, M. et al. Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer. Int. J. Clin. Oncol. 18, 132\u2013138 (2013).","journal-title":"Int. J. Clin. Oncol."},{"key":"1429_CR6","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/annonc\/mdu186","volume":"25","author":"U Nitz","year":"2014","unstructured":"Nitz, U., Gluz, O., Huober, J., Kreipe, H. H., Kates, R. E., Hartmann, A. et al. Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression. Ann. Oncol. 25, 1551\u20131557 (2014).","journal-title":"Ann. Oncol."},{"key":"1429_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3109\/0284186X.2014.995775","volume":"54","author":"M Ewertz","year":"2015","unstructured":"Ewertz, M., Qvortrup, C. & Eckhoff, L. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives. Acta Oncol. 54, 587\u2013591 (2015).","journal-title":"Acta Oncol."},{"key":"1429_CR8","doi-asserted-by":"publisher","unstructured":"Bandos, H., Melnikow, J., Rivera, D. R., Swain, S. M., Sturtz, K., Fehrenbacher, L. et al. Long-term peripheral neuropathy in breast cancer patients treated with adjuvant chemotherapy: NRG Oncology\/NSABP B-30. J. Natl Cancer Inst. 110, https:\/\/doi.org\/10.1093\/jnci\/djx162 (2018).","DOI":"10.1093\/jnci\/djx162"},{"key":"1429_CR9","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1200\/JOP.2012.000863","volume":"9","author":"RM Speck","year":"2013","unstructured":"Speck, R. M., Sammel, M. D., Farrar, J. T., Hennessy, S., Mao, J. J., Stineman, M. G. et al. Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer. J. Oncol. Pract. 9, e234\u2013e240 (2013).","journal-title":"J. Oncol. Pract."},{"key":"1429_CR10","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1200\/JCO.2012.41.7238","volume":"30","author":"DR Pachman","year":"2012","unstructured":"Pachman, D. R., Barton, D. L., Swetz, K. M. & Loprinzi, C. L. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J. Clin. Oncol. 30, 3687\u20133696 (2012).","journal-title":"J. Clin. Oncol."},{"key":"1429_CR11","doi-asserted-by":"publisher","unstructured":"Rivera, D. R., Ganz, P. A., Weyrich, M. S., Bandos, H. & Melnikow, J. Chemotherapy-Associated peripheral neuropathy in patients with early-stage breast cancer: a systematic review. J. Natl Cancer Inst. 110, https:\/\/doi.org\/10.1093\/jnci\/djx140 (2018).","DOI":"10.1093\/jnci\/djx140"},{"key":"1429_CR12","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R. et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155, 2461\u20132470 (2014).","journal-title":"Pain"},{"key":"1429_CR13","doi-asserted-by":"publisher","unstructured":"Greenlee, H., Hershman, D. L., Shi, Z., Kwan, M. L., Ergas, I. J., Roh, J. M. et al. BMI, lifestyle factors and taxane-induced neuropathy in breast cancer patients: the Pathways Study. J. Natl Cancer Inst. 109, https:\/\/doi.org\/10.1093\/jnci\/djw206 (2017).","DOI":"10.1093\/jnci\/djw206"},{"key":"1429_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10549-016-3939-0","volume":"159","author":"T Bao","year":"2016","unstructured":"Bao, T., Basal, C., Seluzicki, C., Li, S. Q., Seidman, A. D. & Mao, J. J. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res. Treat. 159, 327\u2013333 (2016).","journal-title":"Breast Cancer Res. Treat."},{"key":"1429_CR15","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1007\/s00415-018-9123-1","volume":"266","author":"T Julian","year":"2019","unstructured":"Julian, T., Glascow, N., Syeed, R. & Zis, P. Alcohol-related peripheral neuropathy: a systematic review and meta-analysis. J. Neurol. 266, 2907\u20132919 (2019).","journal-title":"J. Neurol."},{"key":"1429_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10654-015-0094-6","volume":"31","author":"R Hanewinckel","year":"2016","unstructured":"Hanewinckel, R., van Oijen, M., Ikram, M. A. & van Doorn, P. A. The epidemiology and risk factors of chronic polyneuropathy. Eur. J. Epidemiol. 31, 5\u201320 (2016).","journal-title":"Eur. J. Epidemiol."},{"key":"1429_CR17","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.clinph.2013.01.025","volume":"124","author":"R Rolke","year":"2013","unstructured":"Rolke, R., Rolke, S., Vogt, T., Birklein, F., Geber, C., Treede, R. D. et al. Hand-arm vibration syndrome: clinical characteristics, conventional electrophysiology and quantitative sensory testing. Clin. Neurophysiol. 124, 1680\u20131688 (2013).","journal-title":"Clin. Neurophysiol."},{"key":"1429_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/1753193410396636","volume":"36","author":"C Heaver","year":"2011","unstructured":"Heaver, C., Goonetilleke, K. S., Ferguson, H. & Shiralkar, S. Hand-arm vibration syndrome: a common occupational hazard in industrialized countries. J. Hand Surg. Eur. Vol. 36, 354\u2013363 (2011).","journal-title":"J. Hand Surg. Eur. Vol."},{"key":"1429_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejca.2016.09.020","volume":"69","author":"F Mols","year":"2016","unstructured":"Mols, F., van de Poll-Franse, L. V., Vreugdenhil, G., Beijers, A. J., Kieffer, J. M., Aaronson, N. K. et al. Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population. Eur. J. Cancer 69, 28\u201338 (2016).","journal-title":"Eur. J. Cancer"},{"key":"1429_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/02841860802247664","volume":"48","author":"L Barlow","year":"2009","unstructured":"Barlow, L., Westergren, K., Holmberg, L. & Talb\u00e4ck, M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 48, 27\u201333 (2009).","journal-title":"Acta Oncol."},{"key":"1429_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J. et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl Cancer Inst. 85, 365\u2013376 (1993).","journal-title":"J. Natl Cancer Inst."},{"key":"1429_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond, A. S. & Snaith, R. P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67, 361\u2013370 (1983).","journal-title":"Acta Psychiatr. Scand."},{"key":"1429_CR23","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","volume":"41","author":"TJ Postma","year":"2005","unstructured":"Postma, T. J., Aaronson, N. K., Heimans, J. J., Muller, M. J., Hildebrand, J. G., Delattre, J. Y. et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur. J. Cancer 41, 1135\u20131139 (2005).","journal-title":"Eur. J. Cancer"},{"key":"1429_CR24","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s11136-017-1626-1","volume":"26","author":"JM Kieffer","year":"2017","unstructured":"Kieffer, J. M., Postma, T. J., van de Poll-Franse, L., Mols, F., Heimans, J. J., Cavaletti, G. et al. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20). Qual. Life Res. 26, 2999\u20133010 (2017).","journal-title":"Qual. Life Res."},{"key":"1429_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/annonc\/mds329","volume":"24","author":"G Cavaletti","year":"2013","unstructured":"Cavaletti, G., Cornblath, D. R., Merkies, I. S., Postma, T. J., Rossi, E., Frigeni, B. et al. The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann. Oncol. 24, 454\u2013462 (2013).","journal-title":"Ann. Oncol."},{"key":"1429_CR26","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s11136-013-0379-8","volume":"22","author":"EM Lavoie Smith","year":"2013","unstructured":"Lavoie Smith, E. M., Barton, D. L., Qin, R., Steen, P. D., Aaronson, N. K. & Loprinzi, C. L. Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Qual. Life Res. 22, 2787\u20132799 (2013).","journal-title":"Qual. Life Res."},{"key":"1429_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/NCC.0000000000000596","volume":"42","author":"EML Smith","year":"2019","unstructured":"Smith, E. M. L., Banerjee, T., Yang, J. J., Bridges, C. M., Alberti, P., Sloan, J. A. et al. Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data. Cancer Nurs. 42, 179\u2013189 (2019).","journal-title":"Cancer Nurs."},{"key":"1429_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/1403494815602830","volume":"44","author":"SJ Olsson","year":"2016","unstructured":"Olsson, S. J., Ekblom, \u00d6., Andersson, E., B\u00f6rjesson, M. & Kallings, L. V. Categorical answer modes provide superior validity to open answers when asking for level of physical activity: a cross-sectional study. Scand. J. Public Health 44, 70\u201376 (2016).","journal-title":"Scand. J. Public Health"},{"key":"1429_CR29","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","volume":"158","author":"K Bush","year":"1998","unstructured":"Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D. & Bradley, K. A. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch. Intern. Med. 158, 1789\u20131795 (1998).","journal-title":"Arch. Intern. Med."},{"key":"1429_CR30","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/aje\/kwg074","volume":"157","author":"LA McNutt","year":"2003","unstructured":"McNutt, L. A., Wu, C., Xue, X. & Hafner, J. P. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am. J. Epidemiol. 157, 940\u2013943 (2003).","journal-title":"Am. J. Epidemiol."},{"key":"1429_CR31","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1200\/JCO.2016.71.3552","volume":"35","author":"KM Winters-Stone","year":"2017","unstructured":"Winters-Stone, K. M., Horak, F., Jacobs, P. G., Trubowitz, P., Dieckmann, N. F., Stoyles, S. et al. Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. J. Clin. Oncol. 35, 2604\u20132612 (2017).","journal-title":"J. Clin. Oncol."},{"key":"1429_CR32","doi-asserted-by":"publisher","unstructured":"Mustafa Ali, M., Moeller, M., Rybicki, L. & Moore, H. C. F. Long-term peripheral neuropathy symptoms in breast cancer survivors. Breast Cancer Res. Treat. https:\/\/doi.org\/10.1007\/s10549-017-4437-8 (2017).","DOI":"10.1007\/s10549-017-4437-8"},{"key":"1429_CR33","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1188\/17.ONF.580-588","volume":"44","author":"EM Lavoie Smith","year":"2017","unstructured":"Lavoie Smith, E. M., Haupt, R., Kelly, J. P., Lee, D., Kanzawa-Lee, G., Knoerl, R. et al. The content validity of a chemotherapy-induced peripheral neuropathy patient-reported outcome measure. Oncol. Nurs. Forum 44, 580\u2013588 (2017).","journal-title":"Oncol. Nurs. Forum"},{"key":"1429_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6352-3","volume":"19","author":"M Wang","year":"2019","unstructured":"Wang, M., Cheng, H. L., Lopez, V., Sundar, R., Yorke, J. & Molassiotis, A. Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time. BMC Cancer 19, 1151 (2019).","journal-title":"BMC Cancer"},{"key":"1429_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5302-4","volume":"19","author":"A Molassiotis","year":"2019","unstructured":"Molassiotis, A., Cheng, H. L., Lopez, V., Au, J. S. K., Chan, A., Bandla, A. et al. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy. BMC Cancer 19, 132 (2019).","journal-title":"BMC Cancer"},{"key":"1429_CR36","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","volume":"34","author":"RD Frisina","year":"2016","unstructured":"Frisina, R. D., Wheeler, H. E., Fossa, S. D., Kerns, S. L., Fung, C., Sesso, H. D. et al. Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J. Clin. Oncol. 34, 2712\u20132720 (2016).","journal-title":"J. Clin. Oncol."},{"key":"1429_CR37","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1212\/WNL.0000000000003293","volume":"87","author":"R Hanewinckel","year":"2016","unstructured":"Hanewinckel, R., Drenthen, J., van Oijen, M., Hofman, A., van Doorn, P. A. & Ikram, M. A. Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurology 87, 1892\u20131898 (2016).","journal-title":"Neurology"},{"key":"1429_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10549-009-0426-x","volume":"120","author":"JA P\u00e9rez-Fidalgo","year":"2010","unstructured":"P\u00e9rez-Fidalgo, J. A., Rosell\u00f3, S., Garc\u00eda-Garr\u00e9, E., Jord\u00e1, E., Mart\u00edn-Martorell, P., Bermejo, B. et al. Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens. Breast Cancer Res. Treat. 120, 245\u2013251 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"1429_CR39","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2147\/CIA.S3466","volume":"3","author":"S Gonnelli","year":"2008","unstructured":"Gonnelli, S. & Petrioli, R. Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer. Clin. Interv. Aging 3, 647\u2013657 (2008).","journal-title":"Clin. Interv. Aging"},{"key":"1429_CR40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamaoncol.2015.1546","volume":"1","author":"ML Neuhouser","year":"2015","unstructured":"Neuhouser, M. L., Aragaki, A. K., Prentice, R. L., Manson, J. E., Chlebowski, R., Carty, C. L. et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women\u2019s health initiative randomized clinical trials. JAMA Oncol. 1, 611\u2013621 (2015).","journal-title":"JAMA Oncol."},{"key":"1429_CR41","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1200\/JCO.2015.66.2346","volume":"34","author":"DL Hershman","year":"2016","unstructured":"Hershman, D. L., Till, C., Wright, J. D., Awad, D., Ramsey, S. D., Barlow, W. E. et al. Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants 65 years or older in southwest oncology group clinical trials. J. Clin. Oncol. 34, 3014\u20133022 (2016).","journal-title":"J. Clin. Oncol."},{"key":"1429_CR42","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1055\/s-0034-1390391","volume":"34","author":"S Bhattacharyya","year":"2014","unstructured":"Bhattacharyya, S. & Helfgott, S. M. Neurologic complications of systemic lupus erythematosus, Sj\u00f6gren syndrome, and rheumatoid arthritis. Semin. Neurol. 34, 425\u2013436 (2014).","journal-title":"Semin. Neurol."},{"key":"1429_CR43","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/jnci\/djp413","volume":"101","author":"M Bryd\u00f8y","year":"2009","unstructured":"Bryd\u00f8y, M., Oldenburg, J., Klepp, O., Bremnes, R. M., Wist, E. A., Wentzel-Larsen, T. et al. Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors. J. Natl Cancer Inst. 101, 1682\u20131695 (2009).","journal-title":"J. Natl Cancer Inst."},{"key":"1429_CR44","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","volume":"31","author":"B Jordan","year":"2020","unstructured":"Jordan, B., Margulies, A., Cardoso, F., Cavaletti, G., Haugnes, H. S., Jahn, P. et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann. Oncol. 31, 1306\u20131319 (2020).","journal-title":"Ann. Oncol."},{"key":"1429_CR45","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10549-010-1278-0","volume":"125","author":"DL Hershman","year":"2011","unstructured":"Hershman, D. L., Weimer, L. H., Wang, A., Kranwinkel, G., Brafman, L., Fuentes, D. et al. Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res. Treat. 125, 767\u2013774 (2011).","journal-title":"Breast Cancer Res. Treat."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01429-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01429-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01429-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T15:16:37Z","timestamp":1658330197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01429-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8,3]]}},"alternative-id":["1429"],"URL":"https:\/\/doi.org\/10.1038\/s41416-021-01429-3","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"15 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Regional Ethics Committee in Link\u00f6ping approved the study (Ref. no. 2016\/548-31). All women who participated in the study gave informed consent by returning the questionnaire. The study was performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study contained no individual person\u2019s data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The dataset analysed during the current study is available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The funding sources played no role in the study. The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work was supported by the Swedish Cancer Society (190224); the Medical Research Council of Southeast Sweden (FORSS-932359); Futurum\u2014The Academy for Health and Care, J\u00f6nk\u00f6ping County Council (575361); Forsknings-ALF (LIO-901261).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}